|
- People With Severe Diabetes Are Cured in Small Trial of New . . .
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes One year later, these 10 patients no longer need insulin The other two patients need much lower doses
- Zimislecel, a novel cell therapy, appears to restore islet . . .
were free from severe hypoglycemic events from day 90 through 1 year; reduced their exogenous insulin use (mean reduction in daily dose: 92%), with 10 of 12 participants (83%) no longer requiring
- World First: Stem Cells Reverse Type 1 Diabetes in Clinical Trial
After testing the technique in mice and non-human primates with success and safety, the team of researchers got their approval for a human clinical trial The trial is ongoing, and three people are currently enrolled
- World’s first: stem cell therapy reverses diabetes
VX-880 is an experimental stem cell-derived therapy being tested in a phase 1 2 clinical trial for people with type 1 diabetes (T1D) who struggle with severe hypoglycemia and have impaired hypoglycemic awareness
- New therapy after islet cell transplant shows promise for . . .
New data from the clinical trial that is testing an investigational therapy after islet cell transplant was presented in Boston on Tuesday, and showed early signs of success in the first three patients, which include Goedel and Gilada
- Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes
TUESDAY, June 25, 2024 (HealthDay News) -- An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial
- Mount Sinai Researchers Move Closer to a Cure for Diabetes
For more than 15 years, researchers at the Icahn School of Medicine at Mount Sinai have worked tirelessly to find a solution to cure diabetes by identifying a drug that could make human beta cells regenerate
|
|
|